Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSC) Depreciation and Depletion (2020 - 2021)

Ensysce Biosciences (ENSC) has disclosed Depreciation and Depletion for 2 consecutive years, with $50.0 as the latest value for Q3 2021.

  • On a quarterly basis, Depreciation and Depletion rose 2.04% to $50.0 in Q3 2021 year-over-year; TTM through Dec 2021 was $151.0, a N/A change, with the full-year FY2021 number at $151.0, down 24.88% from a year prior.
  • Depreciation and Depletion was $50.0 for Q3 2021 at Ensysce Biosciences, roughly flat from $50.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $52.0 in Q4 2020 to a low of $49.0 in Q3 2020.